METHODS, COMPOSITIONS AND COMPONENTS FOR CRISPR-Cas9 EDITING OF TGFBR2 IN T CELLS FOR IMMUNOTHERAPY
MA50858AUndetermined Publication Date: 2020-09-09EDITAS MEDICINE INC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MA50858
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2017-11-01
- Filing Date
- 2018-11-01
- Publication Date
- 2020-09-09
Need to check novelty before this filing date? Find Prior Art
No text content released.